Animal alternatives
This article was originally published in The Rose Sheet
Executive Summary
Ecotoxicology, good cell culture practice, in vitro models for testing long term (chronic) toxicity, target organ toxicity and acute toxicity testing will be among issues addressed during Centre for Alternative and Complementary Methods to Animal Testing 13th Congress on Alternatives to Animal Testing, slated to take place June 2-4 in Linz, Austria. Additional topics include the EU REACH chemicals policy and "ethical and legal aspects in animal experimentation"...
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.